信息發展(300469.SZ)擬出售參股子公司杭州華亭10%股權
格隆匯5月21日丨信息發展(300469.SZ)公佈,公司擬將合法持有並正常經營的杭州華亭科技有限公司(“杭州華亭”)的133.3334萬元出資額(股權比例10%)全部轉讓給杭州華亭用於減少註冊資本。
華亭科技系一家專業提供司法行政信息化應用整體解決方案的高新技術企業,解決方案包括一卡通產品線、治本安全產品線、安防指揮產品線和監管安全產品線。
經各方友好協商同意此次股權轉讓的價款總計人民幣330萬元。此次交易遵循了公平、公開、合理的原則,決策程序嚴格按照法律、法規及公司的相關制度進行,交易定價公允,符合市場原則。不存在損害公司及股東,特別是中小股東利益的情形。此次交易不會對公司正常經營和持續發展造成不利影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.